Inventors:
Darrow E. Haagensen - Sacramento CA
International Classification:
G01N 3353, G01N 33574
Abstract:
This invention relates to a method of determining, in a subject having active breast gross cystic disease, the risk of future breast cancer development. The level of glycoprotein GCDFP-15 in the plasma is measured at the time of cyst aspiration in order to provide an indication as to the likelihood of future breast cancer development.